BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 15640349)

  • 1. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors.
    Milne TA; Hughes CM; Lloyd R; Yang Z; Rozenblatt-Rosen O; Dou Y; Schnepp RW; Krankel C; Livolsi VA; Gibbs D; Hua X; Roeder RG; Meyerson M; Hess JL
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):749-54. PubMed ID: 15640349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue.
    Horiguchi K; Yamada M; Satoh T; Hashimoto K; Hirato J; Tosaka M; Yamada S; Mori M
    Clin Cancer Res; 2009 Apr; 15(8):2620-9. PubMed ID: 19318494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c.
    Karnik SK; Hughes CM; Gu X; Rozenblatt-Rosen O; McLean GW; Xiong Y; Meyerson M; Kim SK
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14659-64. PubMed ID: 16195383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haploinsufficient and predominant expression of multiple endocrine neoplasia type 1 (MEN1)-related genes, MLL, p27Kip1 and p18Ink4C in endocrine organs.
    Taguchi R; Yamada M; Horiguchi K; Tomaru T; Ozawa A; Shibusawa N; Hashimoto K; Okada S; Satoh T; Mori M
    Biochem Biophys Res Commun; 2011 Nov; 415(2):378-83. PubMed ID: 22037578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis.
    Scacheri PC; Davis S; Odom DT; Crawford GE; Perkins S; Halawi MJ; Agarwal SK; Marx SJ; Spiegel AM; Meltzer PS; Collins FS
    PLoS Genet; 2006 Apr; 2(4):e51. PubMed ID: 16604156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression.
    Yokoyama A; Wang Z; Wysocka J; Sanyal M; Aufiero DJ; Kitabayashi I; Herr W; Cleary ML
    Mol Cell Biol; 2004 Jul; 24(13):5639-49. PubMed ID: 15199122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
    Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
    Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of transformation by MLL.
    Hess JL
    Crit Rev Eukaryot Gene Expr; 2004; 14(4):235-54. PubMed ID: 15663355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between menin and Dnmt1 reversibly regulates pancreatic cancer cell growth downstream of the Hedgehog signaling pathway.
    Cheng P; Wang YF; Li G; Yang SS; Liu C; Hu H; Jin G; Hu XG
    Cancer Lett; 2016 Jan; 370(1):136-44. PubMed ID: 26454216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors.
    Bai F; Pei XH; Nishikawa T; Smith MD; Xiong Y
    Mol Cell Biol; 2007 Feb; 27(4):1495-504. PubMed ID: 17145768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells.
    Schnepp RW; Chen YX; Wang H; Cash T; Silva A; Diehl JA; Brown E; Hua X
    Cancer Res; 2006 Jun; 66(11):5707-15. PubMed ID: 16740708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menin critically links MLL proteins with LEDGF on cancer-associated target genes.
    Yokoyama A; Cleary ML
    Cancer Cell; 2008 Jul; 14(1):36-46. PubMed ID: 18598942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.
    Yokoyama A; Somervaille TC; Smith KS; Rozenblatt-Rosen O; Meyerson M; Cleary ML
    Cell; 2005 Oct; 123(2):207-18. PubMed ID: 16239140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function.
    Lindberg D; Akerström G; Westin G
    Neoplasia; 2007 Jul; 9(7):533-5. PubMed ID: 17710155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression.
    Chen YX; Yan J; Keeshan K; Tubbs AT; Wang H; Silva A; Brown EJ; Hess JL; Pear WS; Hua X
    Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1018-23. PubMed ID: 16415155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).
    Thakker RV
    Mol Cell Endocrinol; 2014 Apr; 386(1-2):2-15. PubMed ID: 23933118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.
    Wu X; Hua X
    Curr Mol Med; 2008 Dec; 8(8):805-15. PubMed ID: 19075677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menin epigenetically represses Hedgehog signaling in MEN1 tumor syndrome.
    Gurung B; Feng Z; Iwamoto DV; Thiel A; Jin G; Fan CM; Ng JM; Curran T; Hua X
    Cancer Res; 2013 Apr; 73(8):2650-8. PubMed ID: 23580576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of DNA damage-dependent cell cycle checkpoints in a menin-deficient model.
    Kottemann MC; Bale AE
    DNA Repair (Amst); 2009 Aug; 8(8):944-52. PubMed ID: 19608464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.